KROS: Keros Therapeutics Inc

14.41 USD 0.25 (1.71%)

Settore: Salute Base: US Dollar Valuta di profitto: US Dollar

Il tasso di cambio KROS ha avuto una variazione del -1.71% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 14.35 e ad un massimo di 14.80.

Segui le dinamiche di Keros Therapeutics Inc. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.

Grafico a schermo intero

KROS News

Zacks 15:40 KROS vs. EXAS: Which Stock Should Value Investors Buy Now?
Zacks 14:54 Will Reblozyl Enable BMY to Offset the Impact of Generic Competition?
Seeking Alpha 13:50 ClearBridge Small Cap Strategy Q2 2025 Commentary
Zacks 15:28 RCKT Stock Up on FDA's RMAT Tag to Gene Therapy for Heart Failure
Zacks 14:39 FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo
Investing 12:05 Keros Therapeutics doses first patient in Phase 3 MDS trial
Reuters 14:41 Fat, not muscle: drugmakers in race for next weight-loss breakthrough
Benzinga 18:37 Keros Therapeutics' Quiet Near-Term Outlook Overshadows Pipeline Potential: Analyst - Keros Therapeutics (NASDAQ:KROS)
Investing 09:05 BofA cuts Keros Therapeutics stock rating, price target to $18
Investing 19:17 Keros directors face significant shareholder dissent
Investing 11:01 Keros Therapeutics to return $375 million to shareholders
Investing 20:16 Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference
Benzinga 16:54 Keros Therapeutics Stops PAH Drug Development, Shrinks Workforce By 45% - Keros Therapeutics (NASDAQ:KROS)
Investing 10:57 Keros Therapeutics halts PAH drug development, cuts workforce
Investing 17:48 Keros secures Glass Lewis support for director nominees
Investing 12:14 ADAR1 calls for Keros to release review results before vote
Investing 12:28 Keros Therapeutics Highlights Commitment to Maximizing Stockholder Value
Seeking Alpha 18:13 Keros Therapeutics (KROS): Strategic Alternatives Could Bring About Value Creation
Benzinga 17:51 Keros Therapeutics Goes Up For Sale On Heels Of Stockholder Rights Plan - Keros Therapeutics (NASDAQ:KROS)
Benzinga 16:12 Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump - CarMax (NYSE:KMX), Keros Therapeutics (NASDAQ:KROS)
Benzinga 14:05 PriceSmart Posts Better-Than-Expected Earnings, Joins Enact Holdings, DexCom And Other Big Stocks Moving Higher On Thursday - Enact Holdings (NASDAQ:ACT), DexCom (NASDAQ:DXCM)
Seeking Alpha 22:25 Keros Therapeutics: Losing Its Lead Drug Is Bad Medicine (NASDAQ:KROS)
Seeking Alpha 14:01 Fidelity Select Health Care Portfolio Q4 2024 Review (Mutual Fund:FSPHX)

Intervallo Giornaliero

14.35 14.80

Intervallo Annuale

9.12 72.37

Chiusura Precedente: 14.48
Apertura: 14.66

Bid: 14.41
Ask: 14.71

Minimo: 14.35
Massimo: 14.80

Volume: 812

Variazione giornaliera: -1.71%
Variazione Mensile: 8.18%

Variazione Semestrale: 29.59%
Variazione Annuale: -71.40%

30 luglio, mercoledì